This is the first part of a scientific statement from the Heart Failure Association (HFA) of the
European Society of Cardiology focused upon the pathophysiology of Takotsubo syndrome …

Takotsubo syndrome (TTS) is identified as an acute severe ventricular systolic dysfunction,
which is usually characterized by reversible and transient akinesia of walls of the ventricle in …

Purpose We set out to summarize the current knowledge on vasoactive drugs and their use
in the management of shock to inform physicians' practices. Methods This is a narrative …

Takotsubo cardiomyopathy (TTS) has become a recognised clinical entity since the
Japanese scientist Sato first described it in 1990. Despite an increasing number of …

The current coronavirus disease 2019 (COVID-19) presents an ongoing medical challenge,
as it involves multiple organs, including the cardiovascular system. Takotsubo syndrome …

Takotsubo syndrome (TTS), also known as stress cardiomyopathy, is a type of acute heart
failure syndrome triggered by intense psychological or physiological stress. TTS typically …

Septic shock is mainly characterized—in addition to hypovolemia—by vasoplegia as a
consequence of a release of inflammatory mediators. Systemic vasodilatation due to …

Takotsubo syndrome (TTS) is an acute heart failure syndrome that mimics the symptoms of
acute myocardial infarction and is often preceded by emotional and/or physical stress. There …

Objectives Takotsubo cardiomyopathy (TCM) is a life-threatening complication of
electroconvulsive therapy (ECT). We report the case of a 66-year-old woman who was …

The novel coronavirus disease 2019 (COVID-19) is associated with several cardiovascular
manifestations including myocardial injury, myocarditis, arrhythmia, and pulmonary …